A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/30 (2006.01)
Patent
CA 2112358
2112358 9323071 PCTABS00028 The invention relates to the use of IGF-1 for the manufacture of a medicament for treatment of Type 1 diabetes mellitus, the medicament comprising a subcutaneous dose not greater than needed to achieve an IGF-1 serum level characteristic for healthy individuals i.e. a physiological replacement of serum IGF-1. This treatment would be especially valuable for the treatment of children or adolescents with Type 1 diabetes mellitus and could lead to improvements in their pubertal growth.
Dunger David B.
Savage Martin O.
Sonksen Peter H.
Chiron Corporation
Fetherstonhaugh & Co.
LandOfFree
Use of igf-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of igf-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of igf-1 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1699818